CWAN (NYSE: CWAN) notice lists 18,700 shares, 93,930-share 10b5-1 sale

Rhea-AI Filing Summary

CWAN submitted a Form 144 notice reporting proposed sales of Common stock tied to option exercises and vested awards. The notice lists 18,700 shares (exercise of stock options), 13,700 shares (exercise, cash), and 5,000 RSUs with dates shown.

The excerpt also lists recent 10b5-1 plan sales, including 93,930 shares on 02/18/2026 and multiple sales of 18,700 shares on other dates with proceeds reported.

Insights

Insider Transactions Analyst

Form 144 lists proposed insider sales and recent 10b5-1 transactions.

The filing records proposed offers to sell Common stock consisting of 18,700 shares (exercise of options), 13,700 shares (cash exercise on 04/15/2026), and 5,000 RSUs dated 01/01/2024. These are routine disclosures required when shares will be sold by affiliates.

Several executed sales are shown as completed under 10b5-1 plans, including 93,930 shares on 02/18/2026 with proceeds listed. The timing and economic effect depend on whether sales are executed under prearranged plans versus discretionary dispositions; subsequent filings will show final sale receipts.

Key Figures

Proposed sale - options: 18,700 shares Proposed sale - cash exercise: 13,700 shares Proposed RSUs: 5,000 shares +3 more

6 metrics

Proposed sale - options 18,700 shares Exercise of stock options (listed under Securities To Be Sold)

Proposed sale - cash exercise 13,700 shares Cash exercise listed with date <date>04/15/2026</date>

Proposed RSUs 5,000 shares Restricted Stock Units dated <date>01/01/2024</date>

Executed 10b5-1 sale 93,930 shares Sale on <date>02/18/2026</date> with proceeds shown

Executed sale example 21,631 shares Sale on <date>03/31/2026</date> with proceeds listed

Proceeds example $2,201,878.88 Proceeds reported for the 93,930-share sale on <date>02/18/2026</date>

Key Terms

Form 144, 10b5-1 Sales Plan, Restricted Stock Units, Exercise of Stock Options

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 Sales Plan regulatory

"10b5-1 Sales Plan for JAMES COX"

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 5000 | 01/01/2024"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Exercise of Stock Options financial

"04/15/2026 | Exercise of Stock Options"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18700	449922.00	296510079	04/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/15/2026	Exercise of Stock Options	Issuer			13700	04/15/2026	Cash
Common	01/01/2024	Restricted Stock Units	Issuer			5000	01/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	03/31/2026	21631	514806.98
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	03/16/2026	18700	436354.91
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	02/18/2026	93930	2201878.88
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	02/17/2026	18700	429404.54

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CWAN's Form 144 report?

It reports proposed sales of Common stock. The notice lists 18,700 shares (options), 13,700 shares (cash exercise), and 5,000 RSUs with dates shown and recent executed sales.

Were any recent insider sales executed for CWAN?

Yes. The excerpt shows multiple 10b5-1 plan sales, including 93,930 shares on 02/18/2026 and sales of 18,700 shares on other dates, with proceeds reported.

Do the listed RSUs and option exercises mean dilution for CWAN?

This filing discloses proposed insider sales and vested awards. It does not state an aggregate dilution impact or whether new shares will be issued beyond the listed amounts.

Are the sales shown part of a 10b5-1 plan for CWAN insiders?

Yes. Several completed sales are identified as executed under a 10b5-1 Sales Plan for the reporting person, with dates and share counts shown in the excerpt.